Skip to main content
Journal cover image

Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.

Publication ,  Journal Article
Weisler, RH; Calabrese, JR; Bowden, CL; Ascher, JA; DeVeaugh-Geiss, J; Evoniuk, G
Published in: J Affect Disord
May 2008

This paper briefly reviews and comments on the development of lamotrigine as a treatment for bipolar disorder. The events described include astute clinical observations by epileptologists, serendipitous coupling of the drug's clinical profile to unmet need of two refractory bipolar patients by a practicing psychiatrist, risk taking on the part of an industry sponsor, and persistence on the part of a few key internal and external advocates to see development through to its conclusion, taking place against a backdrop of a disease area which, at the time of the earliest events described here, had not seen the development of any new pharmacologic treatments for decades. Fortunately for patients, since that time there has been a veritable explosion of research into treatments for bipolar disorder, both old and new, so that now patients and physicians have multiple evidence-based options for the treatment of this devastating illness. The development of lamotrigine provides one example of the importance of prescience, patience and persistence in bringing a novel idea to clinical fruition.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Affect Disord

DOI

ISSN

0165-0327

Publication Date

May 2008

Volume

108

Issue

1-2

Start / End Page

1 / 9

Location

Netherlands

Related Subject Headings

  • Triazines
  • Psychiatry
  • Male
  • Lithium Carbonate
  • Lamotrigine
  • Humans
  • Female
  • Epilepsy
  • Drug Industry
  • Clinical Trials as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Weisler, R. H., Calabrese, J. R., Bowden, C. L., Ascher, J. A., DeVeaugh-Geiss, J., & Evoniuk, G. (2008). Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. J Affect Disord, 108(1–2), 1–9. https://doi.org/10.1016/j.jad.2007.09.012
Weisler, Richard H., Joseph R. Calabrese, Charles L. Bowden, John A. Ascher, Joseph DeVeaugh-Geiss, and Gary Evoniuk. “Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.J Affect Disord 108, no. 1–2 (May 2008): 1–9. https://doi.org/10.1016/j.jad.2007.09.012.
Weisler RH, Calabrese JR, Bowden CL, Ascher JA, DeVeaugh-Geiss J, Evoniuk G. Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. J Affect Disord. 2008 May;108(1–2):1–9.
Weisler, Richard H., et al. “Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.J Affect Disord, vol. 108, no. 1–2, May 2008, pp. 1–9. Pubmed, doi:10.1016/j.jad.2007.09.012.
Weisler RH, Calabrese JR, Bowden CL, Ascher JA, DeVeaugh-Geiss J, Evoniuk G. Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. J Affect Disord. 2008 May;108(1–2):1–9.
Journal cover image

Published In

J Affect Disord

DOI

ISSN

0165-0327

Publication Date

May 2008

Volume

108

Issue

1-2

Start / End Page

1 / 9

Location

Netherlands

Related Subject Headings

  • Triazines
  • Psychiatry
  • Male
  • Lithium Carbonate
  • Lamotrigine
  • Humans
  • Female
  • Epilepsy
  • Drug Industry
  • Clinical Trials as Topic